Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] disability We at the FSH Society have long believed that helping individuals and families with FSHD meet one another is one of the most important services that we provide. It’s […]
[…] drugs would potentially provide the first treatment option for slowing or stopping disease progression in FSHD. By screening drug libraries in FSHD cells grown in the laboratory, we have identified […]
[…] The Society’s track record of success in advancing research initiatives in facioscapulohumeral muscular dystrophy ( FSHD) is unmatched, and I am excited about working collaboratively with the founder, our involved […]
[…] of FSH Watch is here! Highlights: Clinical Trial Research Network receives major NIH award World FSHD Day 2017 FSHD Family Day Conference in Columbus, Ohio Bone health and FSHD FSH […]
Letter from Avidity Biosciences to the FSHD community: Dear FSHD Community, Today, we are very pleased to share with you that we have completed enrollment in the biomarker cohort in […]
